Plain-English translation of NCT07825363 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This trial is testing the NIRSense Tissue Oximetry Sensor System, a small, wearable patch that sticks to your skin and continuously measures how much oxygen is reaching your tissues and how well your heart is pumping. The sensor uses light technology to peek just below the skin's surface and give doctors real-time information about your condition, which could help them spot problems earlier and treat you faster.
Cardiogenic shock—when the heart suddenly can't pump blood effectively—is a medical emergency with a poor outlook, especially in heart attack patients. Right now, doctors rely on tests and blood draws done every few hours, which means they might miss warning signs of decline. The new treatment could provide doctors with continuous, around-the-clock monitoring so they can catch problems and start treatment before your condition gets worse.
You likely qualify if…
You likely don't qualify if…
If you join this study, the research team will place small sensor patches on your chest, forearm, and possibly other locations on your body. These patches will stay in place for about 24 to 72 hours while you are in the cardiac intensive care unit, continuously sending information to a tablet display. The patches may be adjusted during any medical procedures you receive, but otherwise your participation is passive—you simply wear them while receiving your regular care.
AI-generated summary from trial data · Sep 17, 2026 · Not medical advice
United States